Skip to main content

Cipla hits 52-wk high on launch of generic remdesivir for Covid-19 patients

Remdesivir is the only USFDA approved emergency use authorization treatment in severe (hospitalised) Covid-19 patients.

from Home Page https://ift.tt/3eizTiK

Comments

Popular posts from this blog